Cargando…
48842 Sponsor types of US interventional COVID-19 studies listed in ClinicalTrials.gov
ABSTRACT IMPACT: Increase understanding of the types of sponsors responding to the COVID-19 pandemic. OBJECTIVES/GOALS: The COVID-19 pandemic has impacted millions of lives globally. To learn more about this disease and find potential diagnostic, treatment, and preventative products, the healthcare...
Autores principales: | Lee, Irene, Cooper, Lisa, Lechner, Doreen Waldron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827753/ http://dx.doi.org/10.1017/cts.2021.499 |
Ejemplares similares
-
Computerized monitoring of COVID-19 trials, studies and registries in ClinicalTrials.gov registry
por: Mayer, Craig S., et al.
Publicado: (2020) -
An Analysis of Sponsors/Collaborators of 69,160 Drug Trials Registered with ClinicalTrials.gov
por: Keezhupalat, Shruthi Muralidharan, et al.
Publicado: (2016) -
COVID-19 pandemic response varies by clinical trial sponsor type
por: Cooper, Lisa, et al.
Publicado: (2021) -
Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019
por: Gresham, Gillian, et al.
Publicado: (2020) -
Some data quality issues at ClinicalTrials.gov
por: Chaturvedi, Neha, et al.
Publicado: (2019)